Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Moran Sean F.
Relationship:   Chief Financial Officer
City:   Columbia
State:   MD
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   143,605    

Indirect Shares

  0      
Direct Value   $2,498,281    

Indirect Value

  $0      
Total Shares   143,605      
Total Value   $2,498,281      


Celsion Corp
 $39,200 Invivo Therapeutics Holdings Corporation
 $23,970 Corbus Pharmaceuticals Holdings, Inc.
 $2,435,111 Celsion Corp
 $39,200 Invivo Therapeutics Holdings Corporation
 $23,970 Corbus Pharmaceuticals Holdings, Inc.
 $2,435,111
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    3   
    0    

     Stock price went up :

    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   1,046.1%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Celsion Corp CLSN Chief Financial Officer 2009-03-17 35,000 2009-01-19 0    Premium*  
            Invivo Therapeutics Holdings Cor... NVIV Acting Chief Financial... 2013-09-03 60,000 2013-08-29 0    Premium*  
            Corbus Pharmaceuticals Holdings,... CRBP Chief Financial Officer 2024-04-10 48,605 2014-11-25 0    Premium*  
* Premium Members only  

Records found :    61         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-18 4 B $1.71 $2,565 D/D 1,500 65,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-20 4 B $1.70 $2,548 D/D 1,500 66,750 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-11-24 4 B $1.78 $2,670 D/D 1,500 68,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-02 4 B $1.79 $1,790 D/D 1,000 69,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-04 4 B $1.72 $1,720 D/D 1,000 70,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-07 4 B $1.69 $1,689 D/D 1,000 71,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-08 4 B $1.68 $1,682 D/D 1,000 72,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-09 4 B $1.67 $1,670 D/D 1,000 73,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-10 4 B $1.61 $1,611 D/D 1,000 74,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2015-12-11 4 B $1.56 $1,559 D/D 1,000 75,250 2.66 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-05-18 4 B $2.39 $71,700 D/D 30,000 105,250 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-05-19 4 B $2.37 $64,583 D/D 27,250 132,450 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-08-17 4 B $3.19 $267,832 D/D 83,960 216,410 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-08-18 4 B $3.48 $226,200 D/D 65,000 281,410 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-08-26 4 B $3.92 $70,168 D/D 17,900 299,310 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-09-08 4 B $5.12 $157,696 D/D 30,800 330,110 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2016-12-02 4 B $7.20 $10,800 D/D 1,500 331,610 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2017-03-13 4 B $9.60 $19,200 D/D 2,000 333,610 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2017-05-11 4 B $6.14 $20,262 D/D 3,300 336,910 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2017-08-11 4 B $5.91 $14,775 D/D 2,500 339,410 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2017-11-10 4 B $7.04 $10,560 D/D 1,500 340,910 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2018-03-14 4 B $6.60 $20,460 D/D 3,100 344,010 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2018-05-15 4 B $5.77 $23,080 D/D 4,000 348,010 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2019-03-14 4 B $6.67 $10,005 D/D 1,500 349,510 2.74 -
CRBP Corbus Pharmaceuticals Ho... Chief Financial Officer   •       –      –    2019-05-14 4 B $7.12 $712 D/D 100 349,610 2.66 -

  61  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed